Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.47 |
| ▸ | F7 | P08709 | 1/20 | 0.46 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24834141 | 0.83 | SSTR4 (0.50) | MAPTKMT2ASSTR4HDAC3HDAC1 | |
| SCHEMBL28376940 | 0.83 | MAPT (0.55) | MAPTKMT2ASSTR4HDAC3HDAC1 | |
| SCHEMBL8384935 | 0.83 | SSTR4 (0.53) | MAPTKMT2ASSTR4HDAC3HDAC1 | |
| SCHEMBL935057 | 0.83 | SSTR4 (0.53) | MAPTKMT2ASSTR4HDAC3HDAC1 | |
| SCHEMBL9971091 | 0.82 | NPC1 (0.46) | MAPTHDAC1HDAC6GAA | |
| SCHEMBL27279094 | 0.81 | SSTR4 (0.51) | MAPTKMT2ASSTR4HDAC3HDAC1 | |
| SCHEMBL2283304 | 0.81 | SSTR4 (0.51) | MAPTKMT2ASSTR4HDAC3HDAC1 | |
| Hydrochloric Acid SCHEMBL4323383 | 0.81 | SSTR4 (0.51) | MAPTKMT2ASSTR4HDAC3HDAC1 | |
| SCHEMBL10928791 | 0.80 | SSTR4 (0.47) | MAPTKMT2ASSTR4HDAC3HDAC1 | |
| SCHEMBL11136765 | 0.80 | POLB (0.49) | MAPTKMT2ASSTR4CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0182166-B1 | PROCESS FOR PREPARING PHENYLISOPROPYLUREA COMPOUNDS | AMERICAN CYANAMID COMPANY (US) | 1989-05-31 | — | — | EP | claimed |
| EP-0182166-A2 | Process for preparing phenylisopropylurea compounds | AMERICAN CYANAMID COMPANY (US) | 1986-05-28 | — | — | EP | claimed |
| US-4578513-A | Process for preparing phenylisopropylurea compounds | AMERICAN CYANAMID COMPANY (US) | 1986-03-25 | — | — | US | claimed |
| US-4039577-A | Process for preparing phenylisopropylurea derivatives | SHOWA DENKO K.K. (JA) | 1977-08-02 | — | — | US | claimed |
| CN-120035584-A | Substituted N-phenyluracils and salts thereof and their use as herbicidal agents | 拜耳公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-114531883-B | Film and method for producing same | 日东电工株式会社 | 2024-07-09 | — | — | CN | disclosed |
| US-20230303549-A1 | SUBSTITUTED HETEROARYLOXYPYRIDINES, THE SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-09-28 | — | — | US | disclosed |
| EP-3795564-A1 | COMPOUND, CURABLE AGENT COMPOSITION, RESIN COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | Asahi Kasei Kabushiki Kaisha (JP) | 2021-03-24 | — | — | EP | disclosed |
| US-9526241-B2 | Dispersants for agricultural applications | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2016-12-27 | — | — | US | disclosed |
| US-9526241-B2 | Dispersants for agricultural applications | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2016-12-27 | — | — | US | disclosed |
| US-9232786-B2 | Dispersants for agricultural applications | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2016-01-12 | — | — | US | disclosed |
| US-9232786-B2 | Dispersants for agricultural applications | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2016-01-12 | — | — | US | disclosed |
| US-4578513-A | Process for preparing phenylisopropylurea compounds | AMERICAN CYANAMID COMPANY (US) | 1986-03-25 | — | — | US | disclosed |
| US-4143061-A | 3-(α,α-Dimethylbenzyl)urea compounds, compositions, and their use as herbicides | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1979-03-06 | — | — | US | disclosed |
| US-4143061-A | 3-(α,α-Dimethylbenzyl)urea compounds, compositions, and their use as herbicides | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1979-03-06 | — | — | US | disclosed |
| US-4039577-A | Process for preparing phenylisopropylurea derivatives | SHOWA DENKO K.K. (JA) | 1977-08-02 | — | — | US | disclosed |
| US-4039577-A | Process for preparing phenylisopropylurea derivatives | SHOWA DENKO K.K. (JA) | 1977-08-02 | — | — | US | disclosed |
| US-4039577-A | Process for preparing phenylisopropylurea derivatives | SHOWA DENKO K.K. (JA) | 1977-08-02 | — | — | US | disclosed |
| US-3972909-A | α,α-Dimethylbenzylureas and use as herbicides | Shova Denko Kabushiki Kaisha (JA) | 1976-08-03 | — | — | US | disclosed |
| US-3972909-A | α,α-Dimethylbenzylureas and use as herbicides | Shova Denko Kabushiki Kaisha (JA) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303549-A1 | SUBSTITUTED HETEROARYLOXYPYRIDINES, THE SALTS THEREOF AND THEIR USE AS HERBICIDAL AGENTS | DDT, AGPS, GMDS | MAPT 4307/4885KMT2A 2025/4885SSTR4 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.